Imagen de perfil
Profit increase
2026. 132,83 %
2027. 665,95 %

Increase in turnover
2026. 121,37 %
2027. 83,34 %

EbiT margin
2026. 3,34 %
2027. 37,42 %

P/E RATIO
2025. -57,4x
2026. 42x
2027. 5,28x

Free cash flow also increases.

Really positive for the share.
Great performance.
2
Imagen de perfil
@Tenbagger2024 The figures actually cry out for a Tenbagger. 🙈
1
Imagen de perfil
@Max095
Chart-technically already three years in a sideways movement. I wonder when the breakout will come. Because there has actually already been some positive news. Good question why the market is still skeptical. 🤷🏻🤷🏻
1
Imagen de perfil
@Tenbagger2024 perhaps when the approval is granted.
@Max095 Approval has already been granted
1
Imagen de perfil
@gr33sk Thanks for the hint. That should actually be a positive signal. Let's see when the masses notice and the price starts to move
Imagen de perfil
@gr33sk
I had read that too, so I wonder what is going on and why there is no breakout.
Because the key figures are really good.
Are we missing something?
1
Imagen de perfil
@Max095
See at
$CAMX and. $KRYS. a similarly long sideways movement. Although there are also mega growth rates here.
I think this could just be a movement in the sector.
And I think that there is potential in the entire biotechnology sector.
I am already invested in Krystel and I also like $CAMX very much.
1
Imagen de perfil
@Tenbagger2024 I think so too. I also have $IOVA in my portfolio as a speculation
Imagen de perfil
@Max095
As a not quite so risky and nice long-term investment, I also like
$EXEL
Maybe something for you too.

Also performs very well here.

https://aktie.traderfox.com/visualizations/US30161Q1040/DI/exelixis-inc
1
Imagen de perfil
@Tenbagger2024 $ATRO perhaps also interesting, apart from the Rocket Lab hype 🚀